Investors

Sterling Accuris Wellness Pvt Ltd is a private limited equity funded organization and its registered office is in Ahmedabad, Gujarat, India. Sterling Accuris Wellness Pvt Ltd is one of the fastest growing pathology laboratory chains in India with a presence across Gujarat, Rajasthan, Madhya Pradesh and Jammu & Kashmir.

Morgan Stanley Private Equity Asia 

Morgan Stanley Private Equity Asia invested in Sterling Accuris Wellness Private Limited. With the infusion of investment in growth capital, Sterling Accuris will be able to accelerate its expansion plans, which should help the company further solidify its position in the market.

Morgan Stanley Private Equity Asia has been one of the leading private equity investors in the Asia-Pacific region since 1993. Healthcare is a core focus for Morgan Stanley PE and this will be the third investment in the Indian healthcare space.

Overall, this investment is an exciting development for both Sterling Accuris and the broader healthcare industry in India. It's clear that Morgan Stanley Private Equity Asia sees a bright future for the company, and look forward to seeing how Sterling Accuris continues to grow and innovate in the coming years, said Mr. Arjun Saigal, Managing Director and Co-Head of Morgan Stanley Private Equity Asia in India.

Mr. Girish Patel, Chairman, Sterling Accuris, has emphasized the importance of building a strong customer-centric brand while providing ethical and market-appropriate pathology diagnostic services. The investment is also a validation of Patel's leadership and vision, as well as his team's hard work over the past years.

Mr. Rajiv Sharma, Managing Director, Sterling Accuris, has emphasized the company's plans to expand its lab network geographically, invest in digital technology to rapidly grow its B2C services, and build a strong R&D capability to develop innovative tests in molecular and genetics.

The investment in Sterling Accuris points to sustained investor interest in the sector that has received tailwinds from the coronavirus pandemic. During the last three years, the company has significantly grown, expanded their lab network, and invested in automation and more advanced technologies. Providing a wide range of routine and specialised tests. The fundraising step of the company is to penetrate deeper into markets and enter new geographies.

Sterling Accuris is well placed to become a leading player in the diagnostic services industry across India given its management strength, deep network and its focus on B2C diagnostics and new testing technologies.